Ensysce Biosciences Inc (ENSCW) earnings · rev $5.2M
Ensysce Biosciences Inc (ENSCW) common stock listed on US.
This ENSCW earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported ENSCW revenue for 2024-12-31 was $5.2M. Net income was -$8.0M. Revenue was up 133.6% from 2023-12-31 to 2024-12-31.
When the next ENSCW 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 133.6% from 2023-12-31 to 2024-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full ENSCW research stays on the stock page; the tape stays on the quote page.
Not investment advice.